Article info
Research ethics
Paper
A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations
- Correspondence to Professor Berna Arda, Department of Medical Ethics, Faculty of Medicine, Ankara University, Ankara, Turkey; arda{at}medicine.ankara.edu.tr
Citation
A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations
Publication history
- Received July 8, 2011
- Revised August 12, 2011
- Accepted September 10, 2011
- First published October 12, 2011.
Online issue publication
January 20, 2012
Article Versions
- Previous version (12 October 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Diagnostic tests for Crimean-Congo haemorrhagic fever: a widespread tickborne disease
- Crimean-Congo haemorrhagic fever presenting with acute compartment syndrome of the extremities (think beyond normal infections)
- Severe Crimean–Congo haemorrhagic fever presented with massive retroperitoneal haemorrhage that recovered without antiviral treatment
- Interferon-stimulated gene 15: a dual activity during hepatitis C virus infection
- Viral haemorrhagic fever in children
- Potential pathway for Crimean Congo haemorrhagic fever virus to enter the UK
- A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders
- Respiratory syncytial virus infection in adults
- Randomised placebo-controlled trials of surgery: ethical analysis and guidelines
- Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak